Abstract
Background
The early and long-term outcomes after pulmonary endarterectomy (PEA) for chronic thromboembolic pulmonary hypertension (CTEPH) have been established by several high-volume centers, but the impact of postoperative residual pulmonary hypertension affecting postoperative clinical parameters remains unclear. This study aims to investigate the institutional surgical results of PEA and to evaluate the efficacy of additional balloon pulmonary angioplasty (BPA) for residual pulmonary hypertension.
Patients and methods
We retrospectively reviewed 222 patients (57.7 ± 12.9 years old, 141 female) who underwent PEA for CTEPH at the National Cerebral and Cardiovascular Center between 2000 and 2020.
Results
The preoperative mean pulmonary artery pressure (mPAP) was 45.6 ± 9.7 mmHg and pulmonary vascular resistance (PVR) was 1062 ± 451 dyne*sec/cm−5. Postoperative mPAP (23.4 ± 11 mmHg, 204 patients, P < 0.001) and PVR (419 ± 291 dyne*sec/cm−5, 199 patients, P < 0.001) significantly improved after PEA. Since 2011, 62 patients (28%) underwent BPA after PEA for “catecholamine dependent” residual PH 1 month after PEA in 14, “scheduled” BPA with residual PH 1 year after PEA in 32, and 16 “symptomatic” patients without residual PH. Their mPAP had significantly improved by PEA (48.1 ± 7.7 to 32.0 ± 10.2 mmHg, P < 0.001), and further improved (33.8 ± 11.1 to 26.5 ± 9.1 mmHg, P < 0.001) after BPA.
Conclusions
PEA provided immediate and substantial improvements in pulmonary hemodynamics and favorable long-term survival. In addition, postoperative BPA improved postoperative clinical parameters for eligible patients regardless of the presence of residual PH.
Similar content being viewed by others
Date availability
The date that support the findings of this study are available from the corresponding author, Hitoshi Matsuda. The deidentified participant date will not be shared.
References
Lewczuk J, Piszko P, Jagas J, Porada A, Sobkowics B, Wrabec K, et al. Prognostic factors in medically treated patients with chronic pulmonary embolism. Chest. 2001;119:818–23.
Madani MM, Auger WR, Pretorius V, Sakakibara N, Kerr KM, Kim NH, et al. Pulmonary endarterectomy: recent changes in a single institution’s experience of more than 2,700 patients. Ann Thorac Surg. 2012;94:97–103.
Ito R, Yamashita J, Sasaki Y, Ikeda S, Ogino H, Chikamori T, et al. Efficacy and safety of balloon pulmonary angioplasty for residual pulmonary hypertension after pulmonary endarterectomy. Int J Cardiol. 2021;334:105–9.
Makowski CT, Rissmiller RW, Bullington WM. Riociguat: a novel new drug for treatment of pulmonary hypertension. Pharmacotherapy. 2015;35:502–19.
Madani MM. Surgical treatment of chronic thromboembolic pulmonary hypertension: pulmonary thromboendarterectomy. Methodist Debakey Cardiovasc Vasc J. 2016;12:213–8.
Ogino H, Ando M, Matsuda H, Minatoya K, Sasaki H, Nakanishi N, et al. Japanese single-center experience of surgery for chronic thromboembolic pulmonary hypertension. Ann Thorac Surg. 2006;82:630–6.
Matsuda H, Ogino H, Minatoya K, Sasaki H, Nakanishi N, Kyotani S, et al. Long-term recovery of exercise ability after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Ann Thorac Surg. 2006;82:1338–43.
Guth S, Wiedenroth CB, Kramm T, Mayer E. Pulmonary endarterectomy for the treatment of chronic thromboembolic pulmonary hypertension. Expert Rev Respir Med. 2016;10:673–84.
Feinstein JA, Goldhaber SZ, Lock JE, Ferndandes SM, Landzberg MJ. Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension. Circulation. 2001;103:10–3.
Jenkins D, Madani M, Fadel E, D’Armini AM, Mayer E. Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension. Eur Respir Rev. 2017;26: 160111.
Committee for Scientific Affairs, The Japanese Association for Thoracic Surgery, Shimizu H, Okada M, Tangoku A, Doki Y, et al. Thoracic and cardiovascular surgeries in japan during 2017: annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg. 2020;68:414–49.
Gall H, Hoeper MM, Richter MJ, Cacheris W, Hinzmann B, Mayer E. An epidemiological analysis of the burden of chronic thromboembolic pulmonary hypertension in the USA, Europe and Japan. Eur Respir Rev. 2017;26: 160121.
Ende-Verhaar YM, Cannegieter SC, Vonk Noordegraaf A, Delcroix M, Pruszczyk P, Mairuhu AT, et al. Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature. Eur Respir J. 2017;49:1601792.
Ishida K, Masuda M, Tanabe N, Matsumiya G, Tatsumi K, Nakajima N. Long-term outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. J Thorac Cardiovasc Surg. 2012;144:321–6.
Miwa H, Tanabe N, Jujo T, Kato F, Anazawa R, Yamamoto K, Naito A, et al. Long-term outcome of chronic thromboembolic pulmonary hypertension at a single Japanese pulmonary endarterectomy center. Circ J. 2018;82:1428–36.
Yanaka K, Nakayama K, Shinke T, Shinkura Y, Taniguchi Y, Kinutani H, Tamada N, et al. Sequential hybrid therapy with pulmonary endarterectomy and additional balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. J Am Heart Assoc. 2018;7: e008838.
Sakurai Y, Takami Y, Amano K, Hiruchi Y, Akita K, Noda M, et al. Predictors of outcomes after Surgery for chronic thromboembolic pulmonary hypertension. Ann Thorac Surg. 2019;108:1154–61.
Ogo T. Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension. Curr Opin Pulm Med. 2015;21:425–31.
Fukui S, Ogo T, Goto Y, Ueda J, Tsuji A, Sanda Y, et al. Exercise intolerance and ventilatory inefficiency improve early after balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension. Int J Cardiol. 2015;180:66–8.
Acknowledgements
Other than the coauthors, 2 surgeons, including Drs Motomi Ando, and Hitoshi Ogino, were involved as operators or conductors of operations during the study period. We would also like to thank enago (www.enago.jp) for English-language editing.
Funding
This article has no funding relevant to its content.
Author information
Authors and Affiliations
Contributions
MN: Conceptualization; Date curation; Formal analysis; Investigation; Methodology; Writing-original draft. YI: Supervision; Validation; Writing-review. HS: Supervision; Validation. YS: Supervision; Validation. TA: Supervision; Validation. JU: Supervision; Validation. AT: Supervision; Validation. TO: Supervision; Validation. HM: Project administration; Investigation; Supervision; Validation; Writing-review& editing. TS: Supervision; Validation.
Corresponding author
Ethics declarations
Conflict of interest
All authors have no conflicts of interests to declare.
IRB information
This study was approved by the institutional review board (M30-065) and was conducted according to the principles of the Declaration of Helsinki. Individual informed consent from each patient was waived given the retrospective study design.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Nishiyama, M., Inoue, Y., Sasaki, H. et al. Long-term outcomes of combined pulmonary endarterectomy and additional balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. Gen Thorac Cardiovasc Surg 71, 291–298 (2023). https://doi.org/10.1007/s11748-022-01872-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11748-022-01872-w